EW vs MSB · P/E 47, rev $1.39B vs P/E 29, rev $98.6M
Edwards Lifesciences Corp (EW) versus Mesabi Trust (MSB) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Mesabi Trust (MSB) is a steel company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported MSB revenue for 2025-01-31 was $98.6M. Net income was $93.3M. MSB currently screens at market cap $324.3M and trailing P/E 28.7.
EW currently screens at market cap $49.91B and trailing P/E 46.9. MSB currently screens at market cap $324.3M and trailing P/E 28.7.
Not investment advice. Open the EW and MSB stock pages for the full models.
Not investment advice.